CS logo
small CS logo
Universität Leipzig, José-Carreras-Haus

Leipzig, Germany

About Universität Leipzig, José-Carreras-Haus


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Goethe University
2
Total Rows: 1

Clinical Trials at Universität Leipzig, José-Carreras-Haus


During the past decade, Universität Leipzig, José-Carreras-Haus conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Evaluation of Efficacy and Safety of Nilotinib in Combination With Chemotherapy in Elderly Patients With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
2012-01-01
2020-03-10
Completed
79
Study of Frontline Dasatinib Plus Chemotherapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL)
2011-11-01
2015-09-01
Completed
19

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsGoethe University: 2Goethe University: 2

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Universität Leipzig, José-Carreras-Haus


According to Clinical.Site data, the most researched conditions in "Universität Leipzig, José-Carreras-Haus" are "Philadelphia Chromsome Positive Acute Lymphoblastic Leukemia" (1 trials) and "Philadelphia Positive Acute Lymphoblastic Leukemia" (1 trials). Many other conditions were trialed in "Universität Leipzig, José-Carreras-Haus" in a lesser frequency.

Clinical Trials Intervention Types at Universität Leipzig, José-Carreras-Haus


Most popular intervention types in "Universität Leipzig, José-Carreras-Haus" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Dasatinib" (1 trials) and "Nilotinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Universität Leipzig, José-Carreras-Haus


The vast majority of trials in "Universität Leipzig, José-Carreras-Haus" are 2 trials for "All" genders.

Clinical Trials Status at Universität Leipzig, José-Carreras-Haus


Currently, there are NaN active trials in "Universität Leipzig, José-Carreras-Haus". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Universität Leipzig, José-Carreras-Haus, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Universität Leipzig, José-Carreras-Haus, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 2Completed: 2